Oxetanes
![eMolecules Spiro[4h-3,1-benzoxazine-4,4'-piperidin]-2(1h)-one | 84060-09-3 | MFCD10566067 | 1g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502192561.JPG-250.jpg)
eMolecules Spiro[4h-3,1-benzoxazine-4,4'-piperidin]-2(1h)-one | 84060-09-3 | MFCD10566067 | 1g
Combi-Blocks | Spiro[4h-3,1-benzoxazine-4,4'-piperidin]-2(1h)-one | 1g | 335354154 | QA-7216 | 95.000 | 84060-09-3 | MFCD10566067 | 218.256 | C12H14N2O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
![eMolecules 2-OXA-6-AZASPIRO[3.3]HEPTANE-6-ETHANAMINE | 54384-40-6 | MFCD13184501 | 1g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502180928.JPG-250.jpg)
eMolecules 2-OXA-6-AZASPIRO[3.3]HEPTANE-6-ETHANAMINE | 54384-40-6 | MFCD13184501 | 1g
AstaTech | 2-OXA-6-AZASPIRO[3.3]HEPTANE-6-ETHANAMINE | 1g | 411870658 | P15344 | 95.000 | 54384-40-6 | MFCD13184501 | 142.202 | C7H14N2O
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Rbn-3143 | 2360853-16-1 | 99.3% | 449.54 g/mol | C22H28FN3O4S | 10 MG
RBN-3143 is a small-molecule, NAD+-competitive catalytic inhibitor of PARP14 with reported nanomolar potency (IC50 ≈ 4 nM). It inhibits PARP14-mediated ADP-ribosylation, stabilizes PARP14 in cell lines, and is provided for research use to support studies of PARP14 biology and inflammatory disease models.
- NAD+-competitive catalytic inhibitor of PARP14.
- Reported IC50 ≈ 4 nM against PARP14.
- Inhibits PARP14-mediated ADP-ribosylation in cell assays.
- Stabilizes PARP14 protein in cell lines.
- High reported chemical purity (~99.3%).
- Available in multiple research pack sizes for laboratory studies.
![eMolecules 1,4-Dioxa-7-aza-spiro[4.4]nonane | 176-33-0 | MFCD09833560 | 5g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502155634.JPG-250.jpg)
eMolecules 1,4-Dioxa-7-aza-spiro[4.4]nonane | 176-33-0 | MFCD09833560 | 5g
J & W PharmLab, LLC | 1,4-Dioxa-7-aza-spiro[4.4]nonane | 5g | 250019946 | 75R0244 | 97.000 | 176-33-0 | MFCD09833560 | 129.159 | C6H11NO2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules Pharmablock 3-bromooxetane 100mg 551055041 PB00217 0 000 39267-79-3 MFCD08544402 136 976 C3H5BrO
Pharmablock 3-bromooxetane 100mg 551055041 PB00217 0 000 39267-79-3 MFCD08544402 136 976 C3H5BrO
STA PHARMACEUTICAL US LLC Fmoc-3-aminooxetane-3-carboxylic acid | 1 g | CAS 1380327-56-9 | MDL MFCD27664829
Fmoc-3-aminooxetane-3-carboxylic acid is a Amino Acid reagent (Subcategory: Unusual AA) sold by WuXi TIDES. Offered in 1 g. Store at 4 °C. SDS available for reference.
Specifications
- CAS: 1380327-56-9
- MDL: MFCD27664829
- InChIKey: QUZXBKMAZQIBQR-UHFFFAOYSA-N
- Molecular Weight: 339.347
- Molecular Formula: C19H17NO5
- Purity: ≥95%
- Container Type: 15 mL HDPE
- Pack Size: 1 g
- Net Weight: 1 g
- Gross Weight: 7.8 g
- Commodity Code: 29329900
- Country Of Origin: China
- IUPAC: 3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)oxetane-3-carboxylic acid
- SMILES: O=C(C1(NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)COC1)O
eMolecules Pharmablock methyl oxetane-3-carboxylate 10g 551101756 PBA08011 1638760-80-1 MFCD22566365 116.116 C5H8O3
Pharmablock methyl oxetane-3-carboxylate 10g 551101756 PBA08011 1638760-80-1 MFCD22566365 116.116 C5H8O3
Medchemexpress LLC Zinc05007751 | 591239-68-8 | 99.3% | 50 MG
ZINC05007751 is a research-grade small-molecule inhibitor of NIMA-related kinase 6 (NEK6) with a reported IC50 of approximately 3.4 μM. It exhibits antiproliferative activity across multiple human cancer cell lines and has reported synergistic effects with cisplatin and paclitaxel in BRCA2-mutated ovarian cancer models. The compound has formula C18H12N2O3, molecular weight 304.30 g/mol, and listed purity 99.33%.
- Inhibits NEK6 with an IC50 of ~3.4 μM.
- Shows antiproliferative activity in various human cancer cell lines.
- Reported synergy with cisplatin and paclitaxel in BRCA2-mutated ovarian cancer models.
- High purity, suitable for research applications.
- Supplied as a 50 mg research pack; soluble in DMSO.
Medchemexpress LLC Purfalcamine 10mg | 1038620-68-6 | 528.62 | C29H33FN8O | 10 MG
Purfalcamine is a selective Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) inhibitor used for antimalarial research. It shows potent enzymatic inhibition (IC50 = 17 nM) and cellular activity (EC50 = 230 nM), causing parasite developmental arrest at the schizont stage. The compound is supplied for research use with characterized purity and composition.
- Selective PfCDPK1 inhibitor
- Potent enzymatic inhibition (IC50 17 nM)
- Demonstrates antimalarial cellular activity (EC50 230 nM)
- Causes parasite developmental arrest at the schizont stage
- High reported chemical purity (99.44%)
- Molecular formula C29H33FN8O and molecular weight 528.62
eMolecules Ambeed / 4-Methylpyridine-26-dicarbonitrile / 250mg / 783629730 / A1388465 / / 21635-92-7 / MFCD00956145 / 143.149 / C8H5N3
Ambeed / 4-Methylpyridine-26-dicarbonitrile / 250mg / 783629730 / A1388465 / / 21635-92-7 / MFCD00956145 / 143.149 / C8H5N3
eMolecules J W PharmLab LLC 3-Bromo-oxetane 500mg 525273023 03R0152 96 000 39267-79-3 MFCD08544402 136 976 C3H5BrO
J W PharmLab LLC 3-Bromo-oxetane 500mg 525273023 03R0152 96 000 39267-79-3 MFCD08544402 136 976 C3H5BrO